Clinical Trials Browser

Interventional × Recurrence × Thyroxine × Clear all

NCT06087068 2023-10-17

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Phase 2 Recruiting

Recurrence, Thyroid Neoplasms